Literature DB >> 9097984

Effects of dietary bile acids on formation of azoxymethane-induced aberrant crypt foci in F344 rats.

M J Seraj1, A Umemoto, A Kajikawa, S Mimura, T Kinouchi, Y Ohnishi, Y Monden.   

Abstract

The present study has demonstrated the influence of bile acids (BAs) on the development and growth of azoxymethane (AOM)-induced aberrant crypt foci (ACF). Male F344 rats were treated with two doses of AOM (15 mg/kg) at 7 days apart and fed either basal MF or MF plus 0.4% of cholic (CA), deoxycholic (DCA), chenodeoxycholic (CDCA), lithocholic (LCA) and ursodeoxycholic (UDCA) acid mixed diets for 8 weeks after the first AOM dose. The mean number of ACF/colon of the rats fed CA, DCA, CDCA and LCA were higher than that of MF-fed group and the differences were statistically significant (P < 0.005). But the mean number of ACFs/colon was significantly (P < 0.005) lower in UDCA diet-fed rats compared to MF. UDCA-fed rats also showed a significant decrease in average crypt multiplicity (number of crypts/focus) of ACF compared to MF alone. The mean number of ACF with > or =5 crypts was about 2.5-3.7 times higher in case of CA, DCA, CDCA and LCA and about 8.2 times lower in UDCA compared to the control MF diet group. In a parallel study, feeding for 18 weeks of the same BAs mixed diets without AOM administration did not significantly induce ACF. Therefore, these data suggest that dietary BAs by themselves do not induce ACF in F344 rats but enhance or, in the case of UDCA, suppress the development and growth of AOM-induced ACF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9097984     DOI: 10.1016/s0304-3835(97)04719-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

Review 1.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

2.  Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes.

Authors:  Akira Miyaki; Peiying Yang; Hsin-Hsiung Tai; Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-16       Impact factor: 4.052

3.  Bile salt-induced apoptosis in human colon cancer cell lines involves the mitochondrial transmembrane potential but not the CD95 (Fas/Apo-1) receptor.

Authors:  Frank-Peter Wachs; René C Krieg; Cecilia M P Rodrigues; Helmut Messmann; Frank Kullmann; Ruth Knüchel-Clarke; Jürgen Schölmerich; Gerhard Rogler; Klaus Schlottmann
Journal:  Int J Colorectal Dis       Date:  2004-09-07       Impact factor: 2.571

4.  Mechanistic roles of epithelial and immune cell signaling during the development of colitis-associated cancer.

Authors:  Renuka Subramaniam; Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  Cancer Res Front       Date:  2016-01-21

5.  Chemoprevention of N-methylnitrosourea-induced colon carcinogenesis by ursodeoxycholic acid-5-aminosalicylic acid conjugate in F344 rats.

Authors:  Tomio Narisawa; Yoko Fukaura; Naomi Takeba; Keiko Nakai
Journal:  Jpn J Cancer Res       Date:  2002-02

6.  Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis.

Authors:  Sinan Wang; Wenxiao Dong; Li Liu; Mengque Xu; Yu Wang; Tianyu Liu; Yujie Zhang; Bangmao Wang; Hailong Cao
Journal:  Mol Carcinog       Date:  2019-03-03       Impact factor: 4.784

7.  Prevention of N-methylnitrosourea-induced colon tumorigenesis by ursodeoxycholic acid in F344 rats.

Authors:  T Narisawa; Y Fukaura; K Terada; H Sekiguchi
Journal:  Jpn J Cancer Res       Date:  1998-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.